A new review in Engineering reveals that CRISPR technologies are revolutionizing regenerative medicine. Scientists from ...

Scientists are exploring gene editing as a way to correct trisomy at the cellular level. Using CRISPR-Cas9, researchers ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR technologies in the field of ...

A team of researchers from the University of Cologne has made an important contribution to understanding the role of the tau ...

CRISPR epigenome editing successfully reactivates silenced genes in Prader-Willi Syndrome, highlighting potential for ...

The CRISPR-Cas gene scissors offer a wide range of potential applications, from the treatment of genetic diseases to antiviral therapies and diagnostics. However, to safely harness their powers, ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

CAMBRIDGE, Mass., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based ...

Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.